What are the alternative medications for rate control in patients with tachycardia who are allergic to beta blockers (Beta Adrenergic Blocking Agents)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For patients allergic to beta blockers, calcium channel blockers such as diltiazem and verapamil are the primary alternatives for rate control, as recommended by the 2024 ESC guidelines 1. When considering alternatives to beta blockers for rate control, it's essential to prioritize medications that can effectively manage heart rate without triggering allergic reactions.

  • Calcium channel blockers like diltiazem and verapamil are preferred options, as they slow heart rate by decreasing conduction through the AV node, with dosing as outlined in the 2010 American Heart Association guidelines 1.
  • Digoxin is another alternative, particularly useful in patients with heart failure, though it works more slowly and is less effective during exercise or high sympathetic states. Key considerations for these alternatives include:
  • Non-dihydropyridine calcium channel blockers like verapamil and diltiazem, which effectively slow heart rate by decreasing conduction through the AV node.
  • Digoxin, which increases vagal tone and directly affects the AV node, providing an additional option for rate control. The most recent guidelines from 2024 1 support the use of these alternatives, emphasizing the importance of effective rate control in managing atrial fibrillation.

From the FDA Drug Label

Beta-blockers: Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction and/or cardiac contractility.

Beta-blockers: Controlled and uncontrolled domestic studies suggest that concomitant use of diltiazem hydrochloride and beta-blockers is usually well tolerated

Alternative medications for rate control if someone is allergic to beta blockers are:

  • Verapamil 2: a calcium channel blocker that can be used for rate control
  • Diltiazem 3: a calcium channel blocker that can be used for rate control Note that Digoxin 4 may also be considered, but its use should be carefully monitored due to potential toxicity.

From the Research

Alternative Medications for Rate Control

If someone is allergic to beta blockers, there are alternative medications that can be used for rate control. These include:

  • Calcium channel blockers, which can effectively lower blood pressure and are approved for treating angina or cardiac dysrhythmias 5
  • Nondihydropyridine calcium channel blockers, such as diltiazem and verapamil, which can reduce the heart rate and are often used in patients with cardiac dysrhythmias or who need β-blockers 5, 6
  • Digoxin, which can help to obtain satisfactory rate control in combination with a beta-blocker, especially in patients with hypotension or an absolute contraindication to beta-blocker treatment 7

Considerations for Specific Patient Groups

For patients with atrial fibrillation (AF) and heart failure (HF) with or without systolic dysfunction, nondihydropyridine calcium channel blockers may be contraindicated 7. However, in patients with HFpEF or AF, the use of nondihydropyridine calcium channel blockers, such as diltiazem and verapamil, may be associated with a lower risk of HF hospitalization compared to β blockers 8. In the acute setting of AF RVR and HFrEF, diltiazem may be a reasonable second-line option for rate control, although more data are needed to validate this conclusion 9.

Potential Side Effects and Interactions

High doses of dihydropyridine calcium channel blockers can cause edema, headache, flushing, and tachycardia, while high doses of verapamil can cause constipation 5. Diltiazem and verapamil also have important drug interactions with digoxin and cyclosporine, among others 5.

Related Questions

Why are non-dihydropyridine (non-DHP) calcium channel blockers recommended over dihydropyridine (DHP) calcium channel blockers for Supraventricular (SV) tachycardia (SVT)?
What is the next step for rate control in a 65-year-old male patient with atrial fibrillation (a fib) on Coreg (carvedilol) 25 mg twice a day (BID) and digoxin 125 µg three times a week, with a reduced ejection fraction and elevated heart rate?
What are the alternative rate control strategies for patients with decompensated heart failure in whom nondihydropyridine calcium channel antagonists (e.g. verapamil, diltiazem) are contraindicated?
What is the difference between dihydropyridine (DHP) and non-dihydropyridine calcium channel blockers?
What is the first-line treatment for atrial fibrillation (AFib) with rapid ventricular response (tachycardia)?
What is the workup for male gynecomastia with normal beta-human chorionic gonadotropin (beta-hCG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, and thyroid panel, but mildly elevated alpha-fetoprotein (AFP)?
What are the directions for taking a Z-pack (Azithromycin)?
Is it beneficial to limit oral (PO) intake during Clostridioides difficile (C. diff) colitis?
What are the alternative medications for rate control in a patient with hyperthyroidism who is allergic to beta blockers (beta-adrenergic blocking agents)?
Why do patients with myasthenia gravis take Bactrim (trimethoprim/sulfamethoxazole) daily?
What is the most likely systemic autoimmune disease to cause the given problem list?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.